The management of cryptogenic fibrosing alveolitis in three regions of the United Kingdom

The case notes of 200 patients with cryptogenic fibrosing alveolitis, from three regions in the United Kingdom, were reviewed, in order to determine how physicians manage this uncommon condition. In the majority of cases (119), the diagnosis was based solely on clinical grounds, with no attempt at histological confirmation of the diagnosis. Transbronchial biopsy was attempted in 66 patients, but was unhelpful in confirming a diagnosis of pulmonary fibrosis in 30% of these patients. Thirty five patients underwent bronchoalveolar lavage, and 15 had an open lung biopsy. Of the 132 patients treated, 110 received prednisolone alone, and the rest a combination of other immunosuppressive agents. The doses and duration of therapy varied considerably. These results suggest that, in the late 1980s, there were wide variations of practice in the management of cryptogenic fibrosing alveolitis in the United Kingdom. This is likely to reflect a paucity of information on the optimum management of this uncommon condition.

This article has been cited by other articles:

				J. J. Swigris, W. G. Kuschner, J. L. Kelsey, and M. K. Gould Idiopathic Pulmonary Fibrosis: Challenges and Opportunities for the Clinician and Investigator Chest, January 1, 2005; 127(1): 275 - 283. [Abstract] [Full Text] [PDF]

				J. J. Swigris, M. K. Gould, and S. R. Wilson Health-Related Quality of Life Among Patients With Idiopathic Pulmonary Fibrosis Chest, January 1, 2005; 127(1): 284 - 294. [Abstract] [Full Text] [PDF]

				H. R. Collard and T. E. King Jr Demystifying Idiopathic Interstitial Pneumonia Arch Intern Med, January 13, 2003; 163(1): 17 - 29. [Abstract] [Full Text] [PDF]

				J. Behr Is "nonusual interstitial pneumonia" an acceptable diagnosis? Eur. Respir. J., November 1, 2002; 20(5): 1069 - 1070. [Full Text] [PDF]

				American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias . This Joint Statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS Board of Directors, June 2001 and by The ERS Executive Committee, June 2001 Am. J. Respir. Crit. Care Med., January 15, 2002; 165(2): 277 - 304. [Full Text] [PDF]

				N Mogulkoc, M H Brutsche, P W Bishop, B Murby, M S Greaves, A W Horrocks, M Wilson, C McCullough, M Prescott, and J J Egan Pulmonary 99mTc-DTPA aerosol clearance and survival in usual interstitial pneumonia (UIP) Thorax, December 1, 2001; 56(12): 916 - 923. [Abstract] [Full Text] [PDF]

				N. MOGULKOC, M. H. BRUTSCHE, P. W. BISHOP, S. M. GREAVES, A. W. HORROCKS, and J. J. EGAN Pulmonary Function in Idiopathic Pulmonary Fibrosis and Referral for Lung Transplantation Am. J. Respir. Crit. Care Med., July 1, 2001; 164(1): 103 - 108. [Abstract] [Full Text] [PDF]

				M. Demedts, A.U. Wells, J.M. Anto, U. Costabel, R. Hubbard, P. Cullinan, H. Slabbynck, G. Rizzato, V. Poletti, E.K. Verbeken, et al. Interstitial lung diseases: an epidemiological overview Eur. Respir. J., July 1, 2001; 18(32_suppl): 2S - 16s. [Abstract] [Full Text] [PDF]

				M Clark, B Cooper, S Singh, M Cooper, A Carr, and R Hubbard A survey of nocturnal hypoxaemia and health related quality of life in patients with cryptogenic fibrosing alveolitis Thorax, June 1, 2001; 56(6): 482 - 486. [Abstract] [Full Text]

				J.P. Utz, J.H. Ryu, W.W. Douglas, T.E. Hartman, H.D. Tazelaar, J.L. Myers, M.S. Allen, and D.R. Schroeder High short-term mortality following lung biopsy for usual interstitial pneumonia Eur. Respir. J., February 1, 2001; 17(2): 175 - 179. [Abstract] [Full Text] [PDF]

				T. King Idiopathic Pulmonary Fibrosis: Diagnosis and Treatment . International Consensus Statement Am. J. Respir. Crit. Care Med., February 1, 2000; 161(2): 646 - 664. [Full Text]

				A. Wells Clinical usefulness of high resolution computed tomography in cryptogenic fibrosing alveolitis Thorax, December 1, 1998; 53(12): 1080 - 1087. [Full Text]

				D. W Mapel, W. C Hunt, R. Utton, K. B Baumgartner, J. M Samet, and D. B Coultas Idiopathic pulmonary fibrosis: survival in population based and hospital based cohorts Thorax, June 1, 1998; 53(6): 469 - 476. [Abstract] [Full Text]

				R M D. Bois Fortnightly Review: Diffuse lung disease: an approach to management BMJ, July 16, 1994; 309(6948): 175 - 175. [Full Text]

				B. T. SOCIETY and S. O. C. COMMITTEE The Diagnosis, Assessment and Treatment of Diffuse Parenchymal Lung Disease in Adults---British Thoracic Society recommendations Thorax, April 1, 1990; 54(90001): 1S - 28. [Full Text]